Strata Critical Medical (SRTA) risk factors, FY2024 10-K

Strata Critical Medical's FY2024 10-K, filed Mar 13, 2025, lists 61 risk factors in 6 groups. There is no earlier 10-K to compare against, so the most company-specific risks are listed below.

Risk factors listed
616 groups
Section length
22k wordsItem 1A

Strata Critical Medical's biggest risks in the FY2024 10-K

  • Strata Critical Medical faces primary risks from its reliance on third-party aircraft operators and concentrated medical customers.

The risks most specific to Strata Critical Medical

  • Risks Related to Our Business and Growth Strategy

    We have incurred significant losses since inception. We expect to incur losses in the future, and we may not be able to achieve or maintain profitability

    We have incurred significant losses since inception and may not achieve or maintain future profitability.

  • Risks Related to Our Business and Growth Strategy

    Any failure to offer high-quality customer support may harm our relationships with fliers or Medical Customers and could adversely affect our reputation, brand, business, financial condition, and results of operations

    Failures in customer support from our Flier Experience team or Medical Logistics Coordinators could harm our reputation and business.

  • Risks Related to Our Business and Growth Strategy

    We are especially vulnerable to delays, cancellations, or flight rescheduling, as we rely on maintaining a high daily aircraft usage rate, and need to aggregate fliers on our by-the-seat flights to lower direct costs to third-party operators

    We rely on maintaining high daily aircraft usage rates and aggregating fliers on by-the-seat flights to lower operator costs.

  • Risks Related to our Medical Segment

    Our reliance on contractual relationships with certain transplant centers, hospitals and Organ Procurement Organizations and other strategic alliances could adversely affect our business

    We depend on contractual relationships with transplant centers, hospitals, and Organ Procurement Organizations for our Medical product line.

  • Risks Related to our Medical Segment

    Our Medical product line relies on a concentrated number of key Medical Customers, including transplant centers, hospitals, and Organ Procurement Organizations

    Our Medical product line relies on a concentrated number of key Medical Customers whose loss would severely impact revenue.

  • Risks Related to our Medical Segment

    The transport of organs involves numerous risks and delivery failures could expose us to liability and have a material adverse effect on our business and reputation

    Strict ischemic time limits for organ transport mean any delivery delays can render organs unusable and cause reputational damage.

  • Risks Related to Our Dependence on Third-Party Providers

    We rely on our third-party operators to provide and operate aircraft. If such third-party operators do not perform adequately or terminate their relationships with us, our costs may increase and our business, financial condition, and results of operations could be adversely affected

    We rely on third-party contractors to own and operate aircraft, and their poor performance or termination would increase our costs.

All 61 risk factors

Headings as the filing states them, in filing order.

Risks Related to Our Business and Growth Strategy

  1. 01We have incurred significant losses since inception. We expect to incur losses in the future, and we may not be able to achieve or maintain profitability
  2. 02If we experience harm to our reputation and brand, our business, financial condition, and results of operations could be adversely affected
  3. 03Any failure to offer high-quality customer support may harm our relationships with fliers or Medical Customers and could adversely affect our reputation, brand, business, financial condition, and results of operations
  4. 04We are subject to risks associated with climate change, including the potential increased impacts of severe weather events on our operations and infrastructure
  5. 05Terrorist attacks, geopolitical conflict or security events may adversely affect our business, financial condition and results of operations
  6. 06We may require substantial additional funding to finance our operations, but adequate additional financing may not be available when we need it, on acceptable terms, or at all
  7. 07As part of our growth strategy, we may engage in future acquisitions that could disrupt our business and have an adverse impact on our financial condition
  8. 08We may be unable to manage our future growth effectively, which could make it difficult to execute our business strategy
  9. 09We are highly dependent on our senior management team and other highly skilled personnel. If we are not successful in attracting or retaining highly qualified personnel, we may not be able to successfully implement our business strategy
  10. 10Our company culture has contributed to our success, and if we cannot maintain this culture as we grow, our business could be harmed
  11. 11Our financial results may fluctuate from quarter to quarter, which makes our results difficult to predict and may cause our results to fall short of expectations
  12. 12Operation of aircraft involves a degree of inherent risk. We could suffer losses and adverse publicity stemming from any accident involving small aircraft, helicopters, or charter flights and, in particular, from any accident involving our third-party aircraft operators
  13. 13We may purchase additional aircraft in the future
  14. 14Our management has limited experience with operating aircraft. We may not be successful in identifying all potential costs and regulatory requirements related to the operation and maintenance of aircraft, and we may incur considerable costs
  15. 15We are especially vulnerable to delays, cancellations, or flight rescheduling, as we rely on maintaining a high daily aircraft usage rate, and need to aggregate fliers on our by-the-seat flights to lower direct costs to third-party operators
  16. 16Our business is dependent on the availability of aircraft fuel. Continued periods of significant disruption in the supply of aircraft fuel could have a significant negative impact on consumer demand, our operating results, and liquidity
  17. 17Our insurance, or that of our third-party aircraft operators, may become too difficult or expensive for us or them to obtain. Increases in insurance costs or reductions in insurance coverage may materially and adversely impact our results of operations and financial position

Risks Related to our Medical Segment

  1. 18Our reliance on contractual relationships with certain transplant centers, hospitals and Organ Procurement Organizations and other strategic alliances could adversely affect our business
  2. 19Our Medical product line relies on a concentrated number of key Medical Customers, including transplant centers, hospitals, and Organ Procurement Organizations
  3. 20The organ transportation market is highly competitive and some providers benefit from proprietary organ preservation technology or additional capabilities that could put us at a disadvantage
  4. 21Our business depends on the availability of organ donors and viable donor organs, which are influenced by factors beyond our control, and any decrease in the availability of viable donor organs could have a material adverse effect on demand for our services and results of operations
  5. 22Reimbursement and funding for medical transport services may be insufficient, adversely affecting our revenue and profitability
  6. 23The transport of organs involves numerous risks and delivery failures could expose us to liability and have a material adverse effect on our business and reputation
  7. 24organ quality, rendering them unusable. Even minor deviations from planned timelines can significantly reduce the chances of a successful transplant, potentially leading to adverse patient outcomes and reputational damage
  8. 25Advancements in technology could make ground or commercial air transport of organs more viable, reducing the need for our private air transportation services
  9. 26The provision of healthcare services is a heavily regulated industry and our medical transportation operations and services may be impacted by regulatory changes, legislative reforms, and civil or criminal enforcement actions

Risks Related to our Passenger Segment

  1. 27The markets for our Passenger offerings are still in relatively early stages of growth, and if such markets do not continue to grow, grow more slowly than we expect, or fail to grow as large as we expect, our business, financial condition, and results of operations could be adversely affected
  2. 28Blade’s Passenger urban air mobility services have grown rapidly since we launched our business in 2014, however, our service offerings are still relatively new, and it is uncertain to what extent market acceptance will continue to grow, if at all
  3. 29We generate a substantial portion of our revenue from the sale of air transportation. Our success depends, in part, on our ability to cost-effectively attract new fliers, retain existing fliers, and increase utilization of our platform by existing fliers
  4. 30If we are not able to successfully enter into new markets and offer new routes and services and enhance our existing offerings, our business, financial condition, and results of operations could be adversely affected
  5. 31We expect to face intense competition in the urban air mobility industry
  6. 32Our prospects and operations may be adversely affected by changes in consumer preferences, discretionary spending, and other economic conditions that affect demand for our services
  7. 33Our Jet and Other product line is reliant on certain customers which could impact our Passenger segment revenue
  8. 34If we are unable to obtain and maintain adequate facilities and infrastructure, we may be unable to offer our existing Passenger flight schedule and to expand or change our Passenger route network in the future, which may have a material adverse impact on our operations
  9. 35Our international operations and any future international expansion strategy will subject us to additional costs and risks, and our plans may not be successful

Risks Related to Our Dependence on Third-Party Providers

  1. 36We rely on our third-party operators to provide and operate aircraft. If such third-party operators do not perform adequately or terminate their relationships with us, our costs may increase and our business, financial condition, and results of operations could be adversely affected
  2. 37If our third-party aircraft operators are unable to match our growth in demand or we are unable to add additional third-party aircraft operators to our platform to meet demand, our costs may increase and our business, financial condition, and results of operations could be adversely affected
  3. 38If we encounter problems with any of our third-party aircraft operators or third-party service providers, such as workforce disruptions, our operations could be adversely affected by a resulting decline in revenue or negative public perception about our services
  4. 39Illegal, improper, or otherwise inappropriate operation of branded aircraft by our third-party aircraft operators, regardless of whether they are operating aircraft on our behalf, could harm our reputation, business, brand, financial condition, and results of operations
  5. 40We rely on third-party web service providers to deliver our offerings to users on our platform, and any disruption of or interference with our use of third-party web services could adversely affect our business, financial condition, and results of operations

Risks Related to Intellectual Property, Cybersecurity, Information Technology and Data Management Practices

  1. 41System failures, defects, errors, or vulnerabilities in our website, applications, backend systems, or other technology systems or those of third-party technology providers could harm our reputation and brand and adversely impact our business, financial condition, and results of operations
  2. 42We rely on our information technology systems to manage numerous aspects of our business. A cyber-based attack of these systems could disrupt our ability to deliver services to our customers and could lead to increased overhead costs, decreased sales, and harm to our reputation
  3. 43If we fail to adequately protect our proprietary intellectual property rights, our competitive position could be impaired and we may lose market share, generate reduced revenue, and incur costly litigation to protect our rights
  4. 44We use open source software in connection with our platform, which may pose risks to our intellectual property
  5. 45Our business is subject to a wide variety of extensive and evolving laws and regulations, which may result in increases in our costs, disruptions to our operations, limits on our operating flexibility, reductions in the demand for air travel, and competitive disadvantages
  6. 46We could be subject to litigation or regulatory investigations, which may be expensive and could divert management attention
  7. 47We may be blocked from or limited in providing or offering our services in certain jurisdictions, and may be required to modify our business model in those jurisdictions as a result
  8. 48operators are required to comply with more stringent or costly regulatory requirements, or other requirements applicable to air transportation services, our revenue and growth could be adversely affected
  9. 49Failure to comply with federal, state, and foreign laws and regulations relating to privacy, data protection, and consumer protection, or the expansion of current laws and regulations or the enactment of new laws or regulations in these areas, could adversely affect our business and our financial condition
  10. 50Failure to comply with applicable privacy and security laws and regulations could result in a material breach of contract with one or more of our Medical Customers, subject us to enforcement actions and adversely affect our business and our financial condition
  11. 51Environmental regulation and liabilities, including new or developing laws and regulations, may increase our costs of operations and adversely affect us

Risks Related to Ownership of Our Securities and Being a Public Company

  1. 52We have in the past and may in the future identify material weaknesses in our internal control over financial reporting
  2. 53If we fail to maintain an effective system of disclosure controls and internal control over financial reporting, our ability to produce timely and accurate financial statements or comply with applicable regulations could be impaired
  3. 54Our Warrants are accounted for as derivative liabilities and are recorded at fair value with changes in fair value for each period reported in earnings, which may have an adverse effect on the market price of our common stock
  4. 55The price of our securities may change significantly, and you could lose all or part of your investment as a result
  5. 56There is no guarantee that the Warrants will ever be in the money, and they may expire worthless
  6. 57We may redeem unexpired Warrants held by former EIC stockholders prior to their exercise at a time that is disadvantageous to those stockholders, thereby making such Warrants worthless
  7. 58We do not expect to declare any dividends in the foreseeable future
  8. 59We may issue additional shares of common stock or other equity securities without your approval, which would dilute your ownership interest in us and may depress the market price of our common stock
  9. 60Provisions in our charter and Delaware law may inhibit a takeover of us, which could limit the price investors might be willing to pay in the future for our common stock and could entrench management
  10. 61Future sales, or the perception of future sales, by us or our stockholders in the public market could cause the market price for the common stock to decline

Other Strata Critical Medical 10-Ks

  • FY2025 10-K risk factors
    59 risks14 new16 dropped42 reworded

    Strata Critical Medical sold its Passenger business to Joby Aero and acquired Keystone to expand organ transplant logistics.

    Filed Mar 03, 2026

About this page

The headings are the filing's own. The one-line readings and the overview are automated and can be wrong: read Item 1A of the 10-K for the exact wording.